KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cardinal Health (CAH) over the last 17 years, with Q4 2025 value amounting to $2.8 billion.

  • Cardinal Health's Cash & Equivalents fell 2711.29% to $2.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 billion, marking a year-over-year decrease of 2711.29%. This contributed to the annual value of $3.9 billion for FY2025, which is 2452.76% down from last year.
  • Latest data reveals that Cardinal Health reported Cash & Equivalents of $2.8 billion as of Q4 2025, which was down 2711.29% from $4.6 billion recorded in Q3 2025.
  • Cardinal Health's 5-year Cash & Equivalents high stood at $5.1 billion for Q2 2024, and its period low was $2.4 billion during Q1 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $3.7 billion (2022), whereas its average is $3.7 billion.
  • Per our database at Business Quant, Cardinal Health's Cash & Equivalents crashed by 3266.65% in 2022 and then surged by 6935.48% in 2023.
  • Over the past 5 years, Cardinal Health's Cash & Equivalents (Quarter) stood at $3.2 billion in 2021, then grew by 15.6% to $3.7 billion in 2022, then grew by 25.64% to $4.6 billion in 2023, then dropped by 17.01% to $3.8 billion in 2024, then fell by 27.11% to $2.8 billion in 2025.
  • Its Cash & Equivalents stands at $2.8 billion for Q4 2025, versus $4.6 billion for Q3 2025 and $3.9 billion for Q2 2025.